Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases-Reply

Affiliations

¹ Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
² Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.

Comparative Study

Silje Watterdal Syversen et al. JAMA. 2022.

. 2022 Apr 19;327(15):1506-1507.

doi: 10.1001/jama.2022.2938.

¹ Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
² Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.

No abstract available

Comment on

Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases.
Javor E, Hauser G, Skelin M. Javor E, et al. JAMA. 2022 Apr 19;327(15):1505-1506. doi: 10.1001/jama.2022.2935. JAMA. 2022. PMID: 35438732 No abstract available.
Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases.
Vande Casteele N. Vande Casteele N. JAMA. 2022 Apr 19;327(15):1506. doi: 10.1001/jama.2022.2932. JAMA. 2022. PMID: 35438733 No abstract available.